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Abstract
Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) imaging mass spectrometry, also called
MALDI-imaging, is a label-free bioanalytical technique used for spatially-resolved chemical analysis of a sample.
Usually, MALDI-imaging is exploited for analysis of a specially prepared tissue section thaw mounted onto glass
slide. A tremendous development of the MALDI-imaging technique has been observed during the last decade.
Currently, it is one of the most promising innovative measurement techniques in biochemistry and a powerful and
versatile tool for spatially-resolved chemical analysis of diverse sample types ranging from biological and plant
tissues to bio and polymer thin films. In this paper, we outline computational methods for analyzing MALDI-
imaging data with the emphasis on multivariate statistical methods, discuss their pros and cons, and give
recommendations on their application. The methods of unsupervised data mining as well as supervised
classification methods for biomarker discovery are elucidated. We also present a high-throughput computational
pipeline for interpretation of MALDI-imaging data using spatial segmentation. Finally, we discuss current challenges
associated with the statistical analysis of MALDI-imaging data.
Introduction
In the last decade, matrix-assisted laser desorption/ioniza-
tion-time of flight (MALDI-TOF) imaging mass spectro-
metry (IMS), also called MALDI-imaging [1], has seen
incredible technological advances in its applications to bio-
logical systems [2-7]. While innovative ten years ago,
applications to human or animal tissues are now fairly
routine with established protocols already in place. New
types of samples are continuously being analyzed (e.g. bac-
terial thin films [3], whole animal body sections [8], plant
tissues [5], polymer films [9], and many more) with the
main focus on proteomics. Although new IMS techniques
are being introduced every year, our recent review [2]
shows that MALDI-imaging plays the leading role in the
new, rapidly developing field of IMS-based proteomics.
This paper consists of two parts. Firstly, we outline com-
putational methods for MALDI-imaging data analysis with
the emphasis on multivariate statistical methods, discuss
their pros and cons, and give recommendations on their
application. We hope to guide molecular biologists and
biochemists through the maze of existing computational
and statistical methods. While this paper does not eluci-
date the basics of existing methodologies, we try to give
clear and concise recommendations on when certain
methods should be applied. Secondly, we discuss current
computational and statistical challenges in analyzing
MALDI-imaging data. MALDI-imaging is a relatively new
field with only a limited amount of laboratories perform-
ing data acquisition, although this number grows rapidly.
Presently, this field has a high entry barrier for a computa-
tional scientist, since only a few datasets are publicly avail-
able. In addition, computational results are normally
presented in proteomics or mass spectrometry journals,
there fore the computational and statistical challenges are
not known in the statistical or bioinformatic communities.
We hope that the second part of this paper will attract
scientists from these communities to contribute to the fas-
cinating field of computational IMS.
As the field of MALDI-imaging is constantly evolving,
novel MALDI-based techniques were recently introduced
such as 3D MALDI-imaging [10], MALDI-FTICR- [11]
or MALDI-Orbitrap-imaging [12]; however, this paper
focuses primarily on conventional MALDI-imaging using
a TOF mass analyzer. We do not consider computational
methods developed for secondary ion mass spectrometry
(SIMS) [13], another leading IMS technique, mainly
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because SIMS is not used in proteomic analysis with its
mass range limited to below 1.0-1.5 kDa. Other emerging
IMS techniques such as desorption electrospray ioniza-
tion (DESI) [14], laser ablation inductively coupled
plasma mass spectrometry (LA-ICP-MS) [15], or nanos-
tructure-initiator mass spectrometry (NIMS) [16], are
not considered either. In general, all computational
methods discussed in this paper can be applied or are
already applied (such as PCA in the context of SIMS, see
later in the text) to all mentioned IMS techniques.
Although we tried to consider only computational meth-
ods available in existing software packages, some meth-
ods require in-house implementation.
MALDI imaging mass spectrometry
Matrix-assisted laser desorption/ionization-time of-flight
imaging mass spectrometry, also called MALDI-imaging,
emerged in the late 1990s [1,17] and has opened new
horizons for application of mass spectrometry in biology
and medicine [18]. Once a sample is prepared for analysis
(that involves mounting of tissue section, plant leaf or
thin agar layer onto a MALDI target plate followed by
matrix application), MALDI-imaging mass spectrometry
measures mass spectra at discrete spatial points, provid-
ing a so-called datacube or hyperspectral image, with a
mass spectrum measured at each pixel; see Figure 1.
A mass spectrum represents the relative abundances of
ionizable molecules with various mass-to-charge (m/z)
values, ranging for MALDI-TOF-IMS from several hun-
dred m/z up to a few tens of thousands m/z. An m/z-
value in MALDI mass spectrometry is usually interpreted
as the molecular mass, since ions with a charge of +1
prevail. An intensity of a spectrum at an m/z-value repre-
sents the relative abundance of a compound with this m/
z-value. Although MALDI is not a quantitative technique,
it can to some extent be used for semi-quantitative com-
parisons based on the relative abundance of molecules
within a spectrum or, after normalization of spectra
(more on it later), between spectra [19].
A state of the art MALDI-imaging dataset comprises a
huge amount of spectra (usually 5,000-50,000 spectra)
with each raw spectrum representing intensities measured
at a large number (usually 10,000-100,000) of small m/z-
bins and describing up to hundreds of different molecules.
For any given m/z-value, the signal intensity at this m/z-
value across all collected spectra can be visualized as a
pseudo-colored image where each pixel is colored accord-
ing to its spectrum intensity (sometimes called as a heat
map), which we call an m/z-image. Definitely, understand-
ing and interpreting such a multitude of spectra or m/z-
images requires computational data mining methods.
Although a dataset can be mined manually, this is a
tedious work. Moreover, manual mining normally results
in a few - sometimes arbitrarily selected - ions of interest,
neglecting the major part of information represented in
the IMS dataset.
An ultimate aim of processing, both manual and auto-
mated, of a MALDI-imaging dataset is to find m/z-values
which correspond to ions of interest. These ions may be
specific to a spatial region, e.g. be well co-localized with an
anatomical region, or express difference between two spa-
tial regions of one sample or between two different sam-
ples, e.g. be discriminative for a tumor region as compared
with a control region. MALDI-imaging, as a non-targeted
and label-free proteomic technique, delivers information
about the wide range of molecules present in a sample
and is well suited for discovery studies, e.g. for biomarker
discovery. Computational methods are of special impor-
tance in discovery studies because manual data examina-
tion normally results in only a few - sometimes arbitrarily
selected - ions. Such incomplete identification can under-
mine discovery. Once ions of interest are revealed with
MALDI-imaging, they can be identified using MS-based
proteomics identification methods; for a short review of
identification strategies used in combination with MALDI-
imaging, see [20].
For a broad review of technological principles and pro-
tocols used in IMS and, particularly, in MALDI-imaging,
see the recent issue of Methods in Molecular Biology
devoted to IMS [21]. Moreover, see recent surveys
[2,22,23] for a mass spectrometric perspective and [3] for
a microbiology perspective.
Computational methods
We have structured this section by grouping computa-
tional methods according to the tasks they perform:
firstly, pre-processing of spectra, then unsupervised data
mining methods which can be used for preliminary data
examination, then supervised classification applied e.g. in
biomarker discovery. A typical MALDI-imaging study
results in a set of ions of interest, which are visualized as
m/z-images corresponding to their m/z-values. In the last
subsection, we discuss visualization of such images.
Pre-processing
A MALDI-imaging dataset represents a set of mass spectra
with two spatial coordinates x and y assigned to each spec-
trum. In the current practice, the pre-processing of
MALDI-imaging mass spectra does not differ much from
spectra pre-processing in the conventional MALDI-MS of
dried droplets and includes (1) normalization, (2) baseline
correction, and, optionally, (3) spectra smoothing and (4)
spectra recalibration. Standard and well-known MALDI-
MS pre-processing methods can be applied to imaging
data. For a discussion of mass spectra pre-processing from
the MALDI-imaging perspective, see [24].
An important part of MALDI-imaging data pre-
processing is the spectra normalization, i.e. scaling each
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spectrum up to some factor for a better intercomparison
of intensities between different spectra. A standard
method is the so-called total ion count (TIC) normaliza-
tion, where for a spectrum its TIC (the sum of all intensi-
ties) is calculated and then all spectrum intensities are
divided by the TIC value. Although there are still debates
on this topic, recent extensive study [25], where TIC and
five other normalization methods were considered,
demonstrated the need for normalization. TIC is the most
popular method and is recommended in general. For
more careful analysis, Deininger et al. [25] recommends to
consider either TIC or median normalization and to select
the proper method by means of visual examination of
exemplary m/z-images after normalization.
Another pre-processing method, which is sometimes
considered separately from the traditional preprocessing
methods listed above, is the peak picking, i.e. selection of
m/z-values which correspond to high and relevant peaks.
The aim of the peak picking is to reduce the number of
m/z-values by neglecting those values corresponding to
Figure 1 MALDI-imaging data acquisition workflow. MALDI-imaging data acquisition workflow and data representation as a datacube or a
hyperspectral image with spatial coordinates x and y and with the mass spectral coordinate m/z. For every pair of coordinates (x, y) one gets a
mass spectrum, for every m/z-value one gets an m/z-image. The so-called jet colormap from blue (lowest intensity) to yellow to red (highest
intensity) was used for m/z-images.
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noise signals or to non-specific baseline signals; for more
on noise and baseline see [26], for more on the physical
TOF model influencing the peak shape see [27], for more
on statistical modelling of noise and baseline see [28].
Various peak picking methods for MALDI mass spectra
are available and are implemented in mass spectrometry
software packages. A recent comparison [29] shows that
the methods which take into account the shape of a peak,
and not just its intensity, perform the best. However,
peak picking in MALDI-imaging poses new problems
due to a large amount of spectra. Several approaches
have been proposed. Firstly, the peak picking can be
applied to the dataset mean spectrum. It is a very fast
method and is implemented, e.g. in the ClinProTools
software (Bruker Daltonik GmbH, Bremen, Germany).
However, this method is not sensitive, since it does not
favor high and relevant peaks presented only in a small
part of a sample. For example, if a peak is present only in
1% of spectra (for an image of 100×100 pixels, this is an
area of 10×10 pixels), then its contribution to the mean
spectrum will be reduced by 100 times as compared to a
low peak present in all spectra (e.g. a matrix peak).
A consensus approach has been proposed [30], where
among spectrum-wise picked peaks, those are selected,
which are found in at least 1% of spectra. A similar
approach, but requiring manual selection of regions of
interest (ROIs) was proposed in [31]. In [30] and [32], for
spectrum-wise peak picking, we applied the Orthogonal
Matching Pursuit method which has complexity O(n2),
where n is the length of a spectrum (usually 10,000-
100,000). In general, one should consider efficient (at
least O(n2)) peak picking methods when applied to
MALDI-imaging data. Designing and performing a spec-
trum-wise peak picking, one should keep in mind an
inherent balance between efficiency and sensitivity.
Firstly, processing all spectra makes the method poten-
tially more sensitive than processing just a part of the
spectra. Secondly, the more peaks are selected per spec-
trum, the more sensitive the method can be. However,
increasing sensitivity in both cases leads to longer proces-
sing times.
When constructing a list of dataset-relevant peaks out
of the spectrum-wise peak lists, m/z-values selected in
different spectra for the same peak can slightly differ.
This effect cannot be completely compensated by the
instrument calibration using reference markers (e.g.
using a mixture of peptides with known molecular
masses) and is caused by instrumental and experimental
variation. In order to counterbalance this effect, a peak
alignment procedure should be applied. Although the
peak alignment is a well-known task in mass spectrome-
try, there are no dedicated studies of peak alignment in
MALDI-imaging. Norris et al. briefly discuss peak align-
ment in the context of MALDI-imaging [24]. We have
proposed an original but simple procedure for alignment
of peaks with respect to the mean spectrum [32], another
group reported the use of the Matlab (The Mathworks
Inc., Natick, MA, USA) routine msalign [33].
Unsupervised data mining
Most statistical learning methods can be divided into two
groups, so-called unsupervised and supervised methods.
Unsupervised methods are used for data mining, can be
applied without any prior knowledge, and aim at revealing
general data structure. Supervised methods (mainly classi-
fication) require specifying at least two groups of spectra
which need to be differentiated, e.g. by finding m/z-values
differentiating spectra of tumor regions from spectra of
control regions. In the context of MALDI-imaging, two
unsupervised approaches have obtained recognition: com-
ponent analysis and spatial segmentation.
Component analysis represents a MALDI-imaging data-
set with few score plots (or score images) and coefficients
of contribution of each score image to each original m/z-
image [34]. Mathematically speaking, a set of score images
is a generating system of all m/z-images, that is, each m/z-
image from the dataset can be represented as a sum of
score images multiplied with respective coefficients. In the
framework of MALDI-imaging, the most well-known
component analysis method is the Principal Component
Analysis (PCA) [34]. Other methods have been also stu-
died: probabilistic latent semantic analysis [35], indepen-
dent component analysis and non-negative matrix
factorization [36]. For a recent comparison of component
analysis methods, see [37].
Principal Component Analysis
In this section, we consider PCA which is the most well-
known component analysis method used for MALDI-
imaging data representation. PCA is a well-established
statistical method and is often exploited for analysis,
visualization, and compression of biological data. PCA
and its variants [34] were early proposed for data mining
in MALDI-imaging. For an illustrative tutorial on PCA
for molecular biologists, see [38]. Using PCA, one can
represent the full dataset with a few score images corre-
sponding to first principal components. These score
images reveal spatial structures hidden in the dataset by
showing prominent spatial patterns (high intensity
regions). However, except for showing the spatial pat-
terns, the interpretation of score images provided by
PCA is problematic. PCA score images can have negative
values which are non-interpretable in terms of mass
spectra intensities. Additionally, PCA score images do
not define regions of interest and should be examined
and interpreted visually. Finally, the way PCA is used
currently (showing score images of first principal compo-
nents and finding m/z-values of highest loadings)
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sometimes fails in selecting m/z-images co-localized with
a score image. The m/z-images found using PCA some-
times look different from the corresponding score
images; see Figure 2 for an illustration of this shortcom-
ing. Some studies reported success in finding m/z-values
using PCA [39], but they used PCA to discriminate two
groups of m/z-values, each with unknown localization,
rather than finding m/z-values for a specific spatial
region. Deininger et al. [38] conclude that PCA is of use
for data evaluation to decide “whether the experiment
was successful or if preparation artifacts are present”.
Spatial segmentation
Spatial segmentation represents a MALDI-imaging data-
set with one image, a segmentation map, where regions
of distinct molecular composition are color coded, see
examples in Figure 3. The spatial segmentation is per-
formed by grouping all spectra by their similarity using
a clustering algorithm. Then, all pixels are pseudo-color
coded according to cluster assignment. Note that a
color is assigned to a cluster, not to a distinct region; a
segmentation map can have several spatially discon-
nected regions of the same color. Several advanced spa-
tial segmentation methods have been proposed:
hierarchical clustering with PCA used as preprocessing
[38,40], and two methods suppressing the pixel-to-pixel
variability which is inherent to MALDI-imaging: cluster-
ing with edge-preserving image denoising [30] and effi-
cient spatially-aware clustering [32]. The last approach
proposes a new spectral distance which accounts for
spatial relations between spectra and presents an effi-
cient distance-based method for finding segmentation
where distances are computed on the fly.
Hierarchical clustering is advantageous providing
clustering results in the form of a dendrogram which
can be interactively analyzed. It is implemented in the
flexImaging software (Bruker Daltonik) and was used in
e.g. [39,40]; for a histopathological discussion see a
recent review [20]. The main flaw of the hierarchical
clustering is that it requires the distance matrix of size
of n×n (n is the number of spectra) to be loaded into
memory, that hinders processing of datasets with a large
number of spectra. Moreover, it is subject to the pixel-
to-pixel variability leading to noisy segmentation maps,
see Figure 3. As for the parameters (distance, linkage)
Deininger et al. [38,40] recommend choosing the Eucli-
dean distance and the Ward linkage.
Clustering suppressing pixel-to-pixel variability has
been recently proposed [30,32]. Both methods outper-
form hierarchical clustering by providing smooth, noise-
less, and detailed segmentation maps. Although no
publicly available implementations are provided yet, the
second method [32] can be relatively easily implemented.
For examples of segmentation maps produced with var-
ious methods, see Figure 3.
Figure 2 PCA analysis of a MALDI-imaging dataset. Illustration of shortcomings of PCA analysis of a MALDI-imaging dataset of a rat brain
coronal section of 10 μm thickness (160 μm spatial resolution, 101×60 pixels, 5053 spectra). A. Score images of first six principal components
(PC). B. For each score image, the m/z-image with the highest loading is plotted. One can see that the visual correlation between a score image
(left) and its highest-loading m/z-image (right) is achieved only for PCs 1, 2, and 5, whereas not achieved for PCs 3, 4, and 6. Thus, the use of
loadings for interpreting score images is not recommended.
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Interpretation of a segmentation map
In contrast to PCA, spatial segmentation maps not only elu-
cidate the spatial structure of the dataset, but can be easily
interpreted in terms of m/z-values associated with a specific
part of revealed spatial structure. Each segmentation
map consists of a given number of clusters, each repre-
sented with its pseudo-color. After a visual examination, if a
cluster represents a region of interest, then the associated
m/z-values can be found as proposed in [30]. A spatial
mask corresponding to the selected cluster is considered
and for eachm/z-image its correlation with this mask is cal-
culated. Finally, co-localized m/z-values with highest and
significant (p-value smaller than 0.05) correlation should be
considered. An illustration is given in Figure 4. So far, this
simple but powerful method is not implemented in major
MALDI-imaging software packages and requires an in-
house implementation. Other more complicated methods
using spatial querying [41,42] have been proposed; the soft-
ware package presented in [41] is publicly available.
High-throughput pipeline for interpretation of MALDI-
imaging data using spatial segmentation
Here, we present our pipeline for interpretation of a
MALDI-imaging dataset using spatial segmentation
which was successfully applied to hundreds of MALDI-
imaging datasets at the Dorrestein Lab, University of
California San Diego; see Figure 5. The characterization
of natural products of bacteria was the main subject of
these studies, see e.g. [43], which involved analysis of
pairwise interactions of many bacterial species under dif-
ferent conditions. Our pipeline was able to process up to
a few hundreds of MALDI-imaging datasets per week,
representing the results in a concise way so that a few
tens of datasets a week could be easily interpreted by one
scientist. Our results were computed and, more impor-
tantly, interpreted in a time comparable with the dataset
acquisition time. In contrast, a manual analysis of a single
MALDI-imaging dataset takes days and, as we found, is
still not as exhaustive and sensitive as the automatic
analysis.
Based on our experience in developing and applying
the MALDI-imaging data analysis pipeline, the following
recommendations can be made. It is of crucial impor-
tance to represent the data in the most understandable
and compact way for a biologist or practitioner, other-
wise large amount of information extracted out of a
MALDI-imaging dataset will not be appreciated. Provid-
ing a segmentation map is only a part of data analysis
process. Interpretation of the segmentation map is as (or
even more) important as the segmentation itself. When
finding co-localized m/z-values based on a segmentation
map, one should consider all m/z-values but not only
those selected by a peak picking. Selecting too many
peaks during the peak picking prior to segmentation is
not always needed, often detailed segmentation does not
need many peaks. Selecting many peaks slows down the
segmentation and can introduce additional variation;
usually 50-200 peaks is a good choice, although it
depends on the analyzed mass range and samples. Mem-
ory requirements of a processing algorithm can be more
important than the computational efficiency because the
available memory is limited whereas the number of
Figure 3 Segmentation maps of the MALDI-imaging dataset. Optical image (A) and segmentation maps (B-F) of the dataset from Figure 2
but with 80 μm spatial resolution. B. Straightforward k-means clustering of spectra. C. Hierarchical clustering (Euclidean distance, complete
linkage) after PCA-reduction of spectra to 70% explained variance. D. Clustering after edge-preserving image denoising; moderate denoising,
reprinted from [30] with permission from American Chemical Society. E-F. Efficient spatially-aware clustering, moderate size of data-adaptive
neighborhood (E) and large size of non-adaptive neighborhood (F), reprinted from [52] with permission from Elsevier.
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spectra increases quadratically with increasing the spatial
resolution. One should consider memory-efficient meth-
ods which have O(n) memory requirements (n is the
number of spectra) and ideally do not require storing the
full dataset in the memory. Once a MALDI-imaging
pipeline is developed and tested, it should be integrated
with other computational tools for mass spectrometry
analysis, that requires at least providing export of all
valuable information into common format.
Supervised classification
In this section we consider how supervised classification
can be used for biomarker discovery. Classification
requires specifying at least two groups of spectra and
aims at differentiating these groups. Let us consider the
task of cancer biomarker discovery which involves com-
parison of tumor and control regions of a biopsy tissue.
One can also compare several tumor sections versus sev-
eral control sections, collected from one or several
patients. A classification algorithm, the so-called classi-
fier, considers two groups of spectra and undergoes train-
ing to be able to discriminate the groups of spectra. If the
training was successful that can be confirmed by a high
classification accuracy (also called as the correct rate or
the recognition rate) close to 100%, then one could apply
the classifier to new spectra to determine their class
(tumor or control), like in [44,45]. However, in biomarker
discovery studies one is interested not only in application
of the classifier to new spectra, but in interpreting the
differences between the tumor and control groups of
spectra which were found by the classifier, namely, in the
tumor-discriminative m/z-values. Later on, molecular
identities of these tumor-discriminative m/z-values can
be established using MS-based proteomics methods.
Currently, classification of MALDI-imaging spectra for
the search of biomarkers is an active area of research.
Lemaire et al. [46] used the StatView 5.0 software (SAS
Institute, Cary, NC) with symbolic discriminant analysis
and statistical tests for the search for a new ovary cancer
biomarker. Groseclose et al. [47] used the ClinProTools
software (Bruker Daltonik) with the support vector
machine algorithm to differentiate adenocarcinoma from
squamous cell carcinoma. Cazares et al. [48] used Clin-
ProTools with the genetic algorithm and the SAS 9.1
Figure 4 Interpretation of a segmentation map of the MALDI-imaging dataset. Spatial segmentation analysis of the MALDI-imaging dataset
from Figure 2 with our algorithm from [30]. A. Segmentation map (two clusters) overlaid with the optical photo of the section. B. Mean
spectrum of spectra from the second cluster. C. Pseudo-colored images of m/z-values spatially co-localized with the second cluster; each title
shows the m/z-value, Pearson correlation between the image and the cluster spatial map, and 90%-quantile image intensity.
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statistical software (SAS Institute) to discriminate pros-
tate cancer. Rauser et al. [20] used the R statistical pack-
age (http://www.r-project.org) with the support vector
machine and artificial neural network algorithms for
classification of HER2 receptor status in breast cancer
tissues.
However, in all above cited studies, the classification
methods developed for conventional MALDI mass spec-
trometry were used, which do not take into account
specifics of MALDI-imaging data. Classification methods
for MALDI-imaging data are still to be developed. Here,
we give several recommendations on the most impor-
tant points to consider when applying classification to
MALDI-imaging data.
Firstly, the compared groups are often imbalanced, that
is, they have significantly different sizes. Classification of
imbalanced data requires special classification and eva-
luation methods, otherwise the classification can be
biased towards a larger group. This issue is well-studied,
and advanced methods for its solution were proposed
[49-51]. In our experience, large number of spectra in
MALDI-imaging normally allows one to compensate
moderate imbalance (up to ten-fold) by simple decima-
tion of the larger group. Namely, we consider only each
k-th spectrum of the larger group, where k should be
adjusted to achieve the balance between groups sizes.
However, for compensating a strong imbalance, advanced
methods (e.g. sampling and cost-sensitive learning) are
recommended, see [49-51].
Secondly, although classification of conventional dried
droplets MS data is evaluated by how close the classifica-
tion accuracy is to 100%, one should not aim at achiving
this theoretically highest possible accuracy in classifica-
tion of MALDI-imaging spectra for the following reasons.
MALDI-imaging spectra show significant heterogeneity
because of technical reasons (noise, tissue mixture at the
available spatial resolution, ions diffusion). Moreover,
one cannot expect the annotation of a tumor region to
be of perfect quality because of manual mistakes and a
lack of the expert time. Additionally, the annotation does
not go down to the cellular or subcellular level, where
real differentiation between cells takes place. All this
leads to classification accuracies lower than 100%. How-
ever, if a classifier produces a low accuracy (close to 50%
for balanced groups), this indicates some problems and
the provided discriminative m/z-values should be consid-
ered with caution. In our experience, the good accuracy
values above 80%.
Thirdly, the discriminative m/z-values provided by the
classification should always be visualized as m/z-images
and manually examined whether their spatial patterns
are relevant (e.g. co-localized with the tumor area).
MALDI-imaging provides a unique way of evaluating
the relevance of m/z-values by their spatial pattern, that
Figure 5 Pipeline for interpretation of a MALDI-imaging dataset. Our pipeline for interpretation of a MALDI-imaging dataset using spatial
segmentation.
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should be done before starting tedious identification of
molecular identities of putative biomarkers.
Visualization of m/z-images
A computational analysis of a MALDI-imaging dataset,
either using unsupervised methods or using supervised
classification, delivers a list of m/z-values of interest. In
order to associate these m/z-values with their molecular
identities, one needs to perform their identification,
usually with MS-based proteomics methods. Before start-
ing identification, one usually examines provided m/z-
values comparing them with the m/z-values known in the
field. If the list contains m/z-values related to each other
in a known manner, this increases the confidence in that
they express biologically relevant information. For exam-
ple, a few m/z-values separated by one unit can corre-
spond to isotopes (in MALDI, ions usually have a charge
of +1). Two m/z-values separated by 17 units can corre-
spond to the same compound before and after the loss of
ammonia. The difference of 18 units corresponds to the
loss of water. The difference of 16 units corresponds
to oxidation of methionine (or another amino acid
side chain). Finally, m/z-values of interest undergo
identification.
Usually, a computational analysis can deliver a long
list of masses, and a simplification and shortening of
this list by not loosing the sensitivity of the automatic
processing is an important task. In the context of
MALDI-imaging, one method, called masses alignment,
was proposed by us [32] and successfully tested in
another study [52]. The main idea of this method is to
group masses corresponding to one peak and then
represent them with one m/z-value. For this purpose,
we use the dataset mean spectrum and align the selected
m/z-values, “moving them” uphill the dataset mean
spectrum so that they merge into the local maxima of
the mean spectrum; see Figure 6 for an illustration. This
method allowed us to reduce the number of m/z-values
without loss of information.
Once m/z-values are provided by a computational ana-
lysis, their m/z-images should be examined in order to
visually correlate their spatial patterns with known spatial
features of the sample. A usual MALDI-imaging study
results in many m/z-images and, as we demonstrated in
[2], the problem of their visualization remains important.
Recall that an m/z-image is a real-valued image showing
mass spectra intensities at the given m/z-value. Usually,
one visualizes an m/z-image using a pseudo-color scale,
assigning gradually changing colors to the intensities.
The first problem faced when using this visualization is
the so-called hot spots, that is separate pixels or small
groups of pixels with artificially high intensities. Such
Figure 6 A method of alignment of selected m/z-values. A method of alignment of selected m/z-values using the dataset mean spectrum.
The mean spectrum is shown in blue. Red triangles indicate m/z-values of interest before the alignment. Green arrows illustrate the process of
alignment. Green triangles show aligned peaks and their m/z-values. Reprinted from [52], Copyright 2011, with permission from Elsevier.
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pixels distort the pseudo-color scale so that other pixels
are shown with insufficient contrast. In order to automa-
tically correct the hot spots, we proposed [2] to suppress
5% of brightest pixels or to use an advanced contrast-
enhancing procedure like histogram equalization, see
Figure 7B-C for an illustration.
The second problem of visualization of m/z-images is
the strong pixel-to-pixel variation which is inherent to
MALDI-imaging technique. In [30], we analyzed this
variation and showed that it has multiplicative nature
with respect to the pixels intensity. That is, the higher
the intensity in some spatial region, the stronger the
noise in this region, which distorts the m/z-image and
hampers visual evaluation of prominent features.
In order to reduce this variability and suppress the
noise, we proposed to apply image denoising to an m/z-
image prior to visualization. Figure 7D illustrates appli-
cation of advanced edge-preserving image denoising
from [30].
Current computational challenges
In this section, we consider current challenges asso-
ciated with the statistical analysis of MALDI-imaging
data. We hope that this discussion will be of interest to
bioinformaticians and statisticians fostering computa-
tional research in this area.
Available software
The commercially available software for MALDI-ima-
ging delivered by mass spectrometry vendors is aimed at
data acquisition and does not provide capabilities for
statistical analysis yet. Bruker Daltonik (Bremen, Ger-
many) delivers flexImaging (visualization) and, option-
ally, ClinProTools (multivariate analysis, PCA,
classification) which however can be used for small
datasets only. Thermo Scientific (Waltham, MA, USA)
provides ImageQuest (visualization). Waters (Manche-
ster, UK) provides HDI Software (visualization) which
can be coupled with MassLynx (peak picking) and Mar-
kerLynx (PCA, orthogonal projection least squares),
although no publications involving MarkerLynx are
known yet. Shimadzu (Nakagyo-ku, Kyoto, Japan) pro-
vides Intensity Mapping (visualization, export). In addi-
tion to vendor-provided software, Novartis (Basel,
Switzerland) provides the BioMap software which can
be used for visualization and calculating basic statistics
of the full dataset or of regions of interest. AB Sciex
(Foster City, CA, USA) provides TissueView which is
Figure 7 Improving visualization of an m/z-image. Improving visualization of an m/z-image by contrast-enhancement and image denoising.
A. An m/z-image from a MALDI-imaging dataset for a transverse section of mouse brain. B. After contrast-enhancement by correcting 5% of the
brightest pixels. C. After contrast-enhancement by histogram equalization. D. After histogram equalization and edge-preserving denoising.
Reprinted from [2] with permission from John Wiley and Sons.
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based on the BioMap software. Currently, in-house
developments are necessary and Matlab is probably the
most popular development and computing environment
in the MALDI-imaging field.
Specific challenges of analyzing MALDI-imaging data
Two general considerations proved to be important in our
practice when developing methods for processing
MALDI-imaging data. Firstly, a MALDI-imaging dataset is
large, that requires computational methods to be runtime
and memory efficient. A typical dataset is comprised of
5,000-50,000 spectra, each having 10,000-100,000 intensity
values. Datasets generated using upcoming high spatial
resolution and high mass resolution MALDI-imaging
techniques (e.g. MALDI-FT-ICR-imaging) or using 3D
MALDI-imaging are several fold larger. At the same time,
the first examination of acquired data is usually done on a
workstation attached to the mass spectrometer. Processing
single datasets on the same workstation is desirable, that
imposes additional constraints regarding memory
demands and computational costs. Ideally, the processing
time should not exceed the acquisition time which is a few
hours for a typical MALDI-imaging dataset. Secondly,
MALDI-imaging data suffers from the strong pixel-to-
pixel variation which can be significantly suppressed by
using methods respecting spatial relations between pixels.
As demonstrated by us, performing image denoising prior
to clustering [30,41] or considering each spectrum
together with its spatial neighbors [32] leads to smoother
and more detailed results. The advantage of respecting
spatial relations between spectra was demonstrated for
other problems as well [53].
Statistical modelling of pixel-to-pixel variability could
help developing processing methods. However, this, as
well as modelling of other statistical effects in MALDI-
imaging data (noise, baseline generation, variability in
the shape of a peak), is a scarcely studied field. Although
a physical model of the time of flights distribution for
MALDI-TOF mass spectrometry was proposed already
in 2005 [27], a little progress is seen since then. The
problem of statistical modelling for MALDI-imaging
data is addressed only marginally [30]. Successful mod-
elling of this data would provide a way of evaluation of
computational methods by using simulated data. Addi-
tionally, the statistical modelling can be used for devel-
opment of computational methods taking into account
the statistical models, e.g. model-based classification
methods or statistical image processing, as it was illu-
strated for SIMS data processing [54].
Quality assurance
Quality assurance for MALDI-imaging data is not devel-
oped yet. There exist no standard operation procedures
for estimating the quality of a full dataset or single
spectra. We have recently proposed a visualization
method for a quick quality check [2], but there is a lot to
be done in this area. Automatic quality evaluation of sin-
gle spectra of a MALDI-imaging dataset is of special
importance, since, due to biochemical complexity of a
sample, and various weakly studied effects of matrix allo-
cation and MALDI ionization, some spectra show artifi-
cial patterns leading to hotspots and distorting
computational analysis. Such artificial spectra could be
detected and removed by methods of outliers detection
developed specifically for MALDI-imaging.
Noise-tolerant statistical learning
When preparing a training set of spectra in a MALDI-
imaging biomarker discovery study, the annotation is
normally done by a visual examination of a sample and
by a manual annotation of regions representing different
classes (e.g. tumor and control). However, due to the
rough character of this annotation, and due to inherent
chemical complexity on the scale resolved by MALDI-
imaging, the annotation can be incorrect for a significant
portion of spectra. For instance, some pixels in the region
annotated as a control one, can contain tumor cells. In
statistical learning, this effect is referred to as classifica-
tion noise or noise in labels [55]. When classifying spec-
tra of a MALDI-imaging dataset, classification methods
tolerating classification noise or, in general, methods
with high generalizability should be considered.
Combination with other 2D imaging modalities
Combination of MALDI-imaging and microscopy images
of stained tissue used in immunohistochemistry can be
used for improvement of MALDI-imaging data analysis.
This approach is of special importance because the spa-
tial resolution of MALDI-imaging is lower than of micro-
scopy and the pixel-to-pixel variability is significantly
stronger. Implementation of this approach requires spe-
cial co-registration methods.
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